BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19664328)

  • 1. [Research advancement on relationship between Epstein-Barr virus and breast cancer].
    He JR; Song EW; Ren ZF
    Ai Zheng; 2009 Aug; 28(8):827-30. PubMed ID: 19664328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus serology and gastric cancer incidence and survival.
    Koshiol J; Qiao YL; Mark SD; Dawsey SM; Abnet CC; Kamangar F; Lennette ET; Dong ZW; Taylor PR
    Br J Cancer; 2007 Dec; 97(11):1567-9. PubMed ID: 17987041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus and breast cancer: serological study in a high-incidence area of nasopharyngeal carcinoma.
    He JR; Tang LY; Yu DD; Su FX; Song EW; Lin Y; Wang SM; Lai GC; Chen WQ; Ren ZF
    Cancer Lett; 2011 Oct; 309(2):128-36. PubMed ID: 21724319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
    Touge C; Agawa H; Sairenji T; Inoue Y
    Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Six anti-Epstein-Barr virus antibodies in healthy adults in a high risk area of nasopharyngeal carcinoma].
    Yi B; Gu YL; Zong YS; Cheng WM; Ji MF
    Ai Zheng; 2009 Aug; 28(8):822-6. PubMed ID: 19664327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma.
    Chan KH; Gu YL; Ng F; Ng PS; Seto WH; Sham JS; Chua D; Wei W; Chen YL; Luk W; Zong YS; Ng MH
    Int J Cancer; 2003 Jul; 105(5):706-9. PubMed ID: 12740922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Performance of the VIDAS automated immunoassay for the determination of Epstein-Barr virus serological status].
    De Ory F; Guisasola ME; Sanz JC; García-Bermejo I
    Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):618-20. PubMed ID: 22854635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of Epstein-Barr virus to infiltrating lymphocytes in breast carcinomas and not malignant cells.
    Khan G; Philip PS; Al Ashari M; Houcinat Y; Daoud S
    Exp Mol Pathol; 2011 Aug; 91(1):466-70. PubMed ID: 21600202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of EBV antibody EA-IgA, Rta-IgG and VCA-IgA and SA in serum and the implication of combined assay in nasopharyngeal carcinoma diagnosis.
    Xia C; Zhu K; Zheng G
    Int J Clin Exp Pathol; 2015; 8(12):16104-10. PubMed ID: 26884888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection.
    Bhaduri-McIntosh S; Landry ML; Nikiforow S; Rotenberg M; El-Guindy A; Miller G
    J Infect Dis; 2007 Feb; 195(4):483-92. PubMed ID: 17230407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute retinal necrosis associated with Epstein-Barr virus: immunohistopathologic confirmation.
    Schaal S; Kagan A; Wang Y; Chan CC; Kaplan HJ
    JAMA Ophthalmol; 2014 Jul; 132(7):881-2. PubMed ID: 24743882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Epstein-Barr virus (EBV) serostatus by enzyme immunoassays: plausibility of the isolated EBNA-1 IgG positive serological profile.
    García T; Tormo N; Gimeno C; Navarro D
    J Infect; 2008 Oct; 57(4):351-3. PubMed ID: 18789535
    [No Abstract]   [Full Text] [Related]  

  • 15. Epstein-Barr virus and breast cancer: lack of evidence for an association in Iranian women.
    Kadivar M; Monabati A; Joulaee A; Hosseini N
    Pathol Oncol Res; 2011 Sep; 17(3):489-92. PubMed ID: 21207256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of VCA (viral capsid antigen) and EBNA1 (Epstein-Barr-virus-encoded nuclear antigen 1) genes of Epstein-Barr virus in Pichia pastoris and application of the products in a screening test for patients with nasopharyngeal carcinoma.
    Hu B; Hong G; Li Z; Xu J; Zhu Z; Li L
    Biotechnol Appl Biochem; 2007 May; 47(Pt 1):59-69. PubMed ID: 17129209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer.
    Huang J; Chen H; Hutt-Fletcher L; Ambinder RF; Hayward SD
    J Virol; 2003 Dec; 77(24):13267-74. PubMed ID: 14645583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of Epstein-Barr virus in breast carcinomas in Tunisia.
    Hachana M; Amara K; Ziadi S; Romdhane E; Gacem RB; Trimeche M
    Pathol Res Pract; 2011 Nov; 207(11):695-700. PubMed ID: 22024152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
    Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A
    J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between clinical stages of nasopharyngeal carcinoma and Epstein-Barr virus antibodies Rta/IgG, EBNA1/IgA, VCA/IgA and EA/IgA].
    Cai YL; Zheng YM; Cheng JR; Wang W; Zhang YN; Wang WH; Wu YS; Zhong WM; Li J; Mo YK
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):509-11. PubMed ID: 20335122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.